RNA for Drug Discovery
- Website
- Location
- Company size
- 1-10 people
- Total raised
- $17M
- Markets
Arpeggio Biosciences careers
Arpeggio builds tools to analyze how a cell's RNA responds to treatment. These tools are being used to help pharmaceutical companies screen for better drugs and find the biomarkers of patient response. The existing standard approaches profile cellular RNAs based on single time points – before and after treatment. In comparison, Arpeggio can take hundreds of high-resolution timed snapshots of RNA and stitch them together into a movie that reveals how and why a drug works with much greater detail - like a cellular "debugger". This type of detail has only become possible in the last few years by combining novel approaches to understanding how RNA is regulated with advances in Machine Learning, and Arpeggio is pioneering the best tools to do this.
Arpeggio Biosciences hasn't added any jobs yet
Get notified when Arpeggio Biosciences posts new jobs.
Joseph Azofeifa
Valuation
$42M
Funded over
1 round
Latest round
Series A (Sep 2022)
Penumbra • Alameda • 3 weeks ago
Spire • United States • $90k – $115k • 3 weeks ago
Quartzy • United States • 4 days ago
SoundHound • United States • $209k – $270k • 2 weeks ago